A composite metric for predicting benefit from spironolactone in heart failure with preserved ejection fraction.
Mark N BelkinJohn E BlairSanjiv J ShahFrancis J AlenghatPublished in: ESC heart failure (2021)
Patients with HFpEF can be quantified by the TS to capture the likelihood of benefit from spironolactone.
Keyphrases